Energyvet Regavet: Veterinary Product Profile

Energyvet Regavet is a named branded product for All animal species according to the manufacturer, including dogs and cats; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

30 mL oral herbal liquid. Intended species: All animal species according to the manufacturer, including dogs and cats.

The current official English leaflet lists an 82.6% herbal extract from Potentilla erecta, Taraxacum officinale, Plantago lanceolata, Veronica officinalis, Pimpinella saxifraga, Zanthoxylum piperitum, Artemisia abrotanum, Gentiana lutea, Marrubium vulgare, Agrimonia eupatoria, Galium verum, and Saxifraga granulata. It also lists sorbitol, cellulose, water, xanthan gum, grapefruit extract below 0.0001%, potassium sorbate, a 0.12% essential-oil mixture, 0.10% silymarin, and a homeopathic polycomponent for Regavet. These leaflet data must not be replaced by the ingredient panel of an older market version.

Energyvet positions Regavet through Five Element, metabolism, liver, gallbladder, detoxification, and solid-lesion support language. Bioinformation and energetic-system descriptions are proprietary or traditional framing, not clinical measures. They should be displayed only as manufacturer rationale, separated from evidence for a finished product.

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

The current official pages establish the named multi-herb formulation and manufacturer use context. No controlled canine or feline oncology trial of the complete Regavet liquid was identified. Traditional frameworks, plant pharmacology, or research on one constituent cannot establish tumour control, improved treatment response, or longer survival from this multi-component product.

The manufacturer page calls for caution where liver or gallbladder disorders are present. The current multi-herb formula, grapefruit constituent, essential oils, sorbitol, silymarin, and homeopathic polycomponent raise drug-metabolism, gastrointestinal, hepatic, anaesthetic, pregnancy, and allergy questions that need individual review. The physical label and current leaflet control any product-pairing or timing warnings; this profile does not reconstruct a schedule.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

The manufacturer presents Regavet as a veterinary herbal product in the Czech Republic. An authorisation for this exact name was not identified in the current Czech register of authorised veterinary medicinal products, and no EU oncology-medicine authorisation was verified. Its precise non-medicinal national category should be confirmed from the label; traditional or energetic classification does not replace legal classification.

Czech Republic; European Union

Record the complete label, bottle, lot, country version, liver and gallbladder history, medicines, and every Energyvet or other supplement. Track appetite, vomiting, diarrhoea, stool, abdominal discomfort, itching, jaundice, urine change, activity, weight, and treatment tolerance. The veterinarian should decide whether chemistry or liver monitoring is appropriate and should preserve objective oncology follow-up.